|
|
News Breaks
|
November 22, 2011
|
| 09:04 EDT |  | PRAN |
| theflyonthewall.com: | Prana receives approval for Alzheimer's trial | | Prana Biotechnology announced that it has received approval from the Austin Health Research Ethics Committee to commence a 12 month Phase II Imaging trial testing PBT2, the Company's drug in development for Alzheimer's Disease. The purpose of the trial, which builds on the success of an earlier Phase IIa clinical trial of PBT2, is to measure physical changes in the brains of participants treated with PBT2 for 12 months, and to consolidate the evidence, over a longer period, of the positive effects of PBT2 on patients' cognition reported in the earlier trial.(1,2) :theflyonthewall.com |
|
|
News For PRAN From The Last 14 Days Check below for free stories on PRAN the last two weeks.
| Sign up for a free trial to see the rest of the stories you've been missing. |
There are no results for these search parameters.
|
|
|
|
